Effects of a Disease Management Program in Individuals with Alpha-1 Antitrypsin Deficiency

REFERENCES

• Ries A L, Bauldoff G S, Carlin B W, Casaburi R, Emery C F, Mahler D A, Make B, Rochester C L, Zuwallack R, Herrerias C. Pulmonary rehabilitation: Joint accp/aacvpr evidence-based clinical practice guidelines. Chest 2007; 131: 4S–42S
   PubMed Web of Science ®Google Scholar
• Hill N S. Pulmonary rehabilitation. Proc Am Thorac Soc 2006; 3: 66–74
   PubMedGoogle Scholar
• Bourbeau J, Julien M, Maltais F, Rouleau M, Beaupre A, Begin R, Renzi P, Nault D, Borycki E, Schwartzman K, et al. Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: A disease-specific self-management intervention. Arch Intern Med 2003; 163: 585–591
   PubMed Web of Science ®Google Scholar
• Boxall A M, Barclay L, Sayers A, Caplan G A. Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients. J Cardiopulm Rehabil 2005; 25: 378–385
   PubMedGoogle Scholar
• Coultas D, Frederick J, Barnett B, Singh G, Wludyka P. A randomized trial of two types of nurse-assisted home care for patients with copd. Chest 2005; 128: 2017–2024
   PubMed Web of Science ®Google Scholar
• Monninkhof E, van der Valk P, van der Palen J, van Herwaarden C, Zielhuis G. Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J 2003; 22: 815–820
   PubMed Web of Science ®Google Scholar
• Rea H, McAuley S, Stewart A, Lamont C, Roseman P, Didsbury P. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 2004; 34: 608–614
   PubMed Web of Science ®Google Scholar
• Gallefoss F, Bakke P S, Rsgaard P K. Quality of life assessment after patient education in a randomized controlled study on asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 159: 812–817
   PubMed Web of Science ®Google Scholar
• Gourley G A, Portner T S, Gourley D R, Rigolosi E L, Holt J M, Solomon D K, Bass G E, Wicke W R, Braden R L. Humanistic outcomes in the hypertension and copd arms of a multicenter outcomes study. J Am Pharm Assoc (Wash) 1998; 38: 586–597
   PubMedGoogle Scholar
• Effing T, Monninkhof E M, van der Valk P D, van der Palen J, van Herwaarden C L, Partidge M R, Walters E H, Zielhuis G A. Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2007, CD002990
   PubMed Web of Science ®Google Scholar
• Campos M A, Wanner A, Zhang G, Sandhaus R A. Trends in the diagnosis of symptomatic patients with alpha1-antitrypsin deficiency between 1968 and 2003. Chest 2005; 128: 1179–1186
   PubMed Web of Science ®Google Scholar
• Jones P W, Quirk F H, Baveystock C M, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The st. George's respiratory questionnaire. Am Rev Respir Dis 1992; 145: 1321–1327
   PubMed Web of Science ®Google Scholar
• Jones P W. St. George's respiratory questionnaire: Mcid. COPD 2005; 2: 75–79
   PubMedGoogle Scholar
• Ware J E, Snow K K, Kosinski M. Sf-36 health survey: Manual and interpretation guide. QualityMetric Incorporated, Lincoln, RI 2002
   Google Scholar
• Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest 2000; 117: 398S–401S
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease (gold), Available at www.Goldcopd.Org Accessed 7/17/07, 2006
   Google Scholar
• Calverley P M, Anderson J A, Celli B, Ferguson G T, Jenkins C, Jones P W, Yates J C, Vestbo J. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356: 775–789
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley P M, Sherwood Burge P, Jones P W. Health status deterioration in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163: 122–128
   PubMed Web of Science ®Google Scholar
• Casaburi R, Mahler D A, Jones P W, Wanner A, San P G, ZuWallack R L, Menjoge S S, Serby C W, Witek T, Jr. A long-term evaluation of once-daily inhaled tiotropium in chronic obstructive pulmonary disease. Eur Respir J 2002; 19: 217–224
   PubMed Web of Science ®Google Scholar
• Donohue J F, van Noord J A, Bateman E D, Langley S J, Lee A, Witek T J, Jr., Kesten S, Towse L. A 6-month, placebo-controlled study comparing lung function and health status changes in copd patients treated with tiotropium or salmeterol. Chest 2002; 122: 47–55
   PubMed Web of Science ®Google Scholar
• Brusasco V, Hodder R, Miravitlles M, Korducki L, Towse L, Kesten S. Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with copd. Thorax 2003; 58: 399–404
   PubMed Web of Science ®Google Scholar
• Niewoehner D E, Rice K, Cote C, Paulson D, Cooper J A, Jr., Korducki L, Cassino C, Kesten S. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: A randomized trial. Ann Intern Med 2005; 143: 317–326
   PubMed Web of Science ®Google Scholar
• Gadoury M A, Schwartzman K, Rouleau M, Maltais F, Julien M, Beaupre A, Renzi P, Begin R, Nault D, Bourbeau J. Self-management reduces both short- and long-term hospitalisation in copd. Eur Respir J 2005; 26: 853–857
   PubMed Web of Science ®Google Scholar
• Adams S G, Smith P K, Allan P F, Anzueto A, Pugh J A, Cornell J E. Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med 2007; 167: 551–561
   PubMed Web of Science ®Google Scholar
• Gallefoss F, Bakke P S. How does patient education and self-management among asthmatics and patients with chronic obstructive pulmonary disease affect medication?. Am J Respir Crit Care Med 1999; 160: 2000–2005
   PubMed Web of Science ®Google Scholar
• Watson P B, Town G I, Holbrook N, Dwan C, Toop L J, Drennan C J. Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 1267–1271
   PubMed Web of Science ®Google Scholar
• Niesink A, Trappenburg J C, de Weert-van Oene G H, Lammers J W, Verheij T J, Schrijvers A J. Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med 2007; 101: 2233–2239
   PubMed Web of Science ®Google Scholar
• Blake R L, Jr., Vandiver T A, Braun S, Bertuso D D, Straub V. A randomized controlled evaluation of a psychosocial intervention in adults with chronic lung disease. Fam Med 1990; 22: 365–370
   PubMedGoogle Scholar
• Howland J, Nelson E C, Barlow P B, McHugo G, Meier F A, Brent P, Laser-Wolston N, Parker H W. Chronic obstructive airway disease. Impact of health education. Chest 1986; 90: 233–238
   PubMed Web of Science ®Google Scholar
• Martin I R, McNamara D, Sutherland F R, Tilyard M W, Taylor D R. Care plans for acutely deteriorating copd: A randomized controlled trial. Chron Respir Dis 2004; 1: 191–195
   PubMedGoogle Scholar
• Desikan R, Mason H L, Rupp M T, Skehan M. Health-related quality of life and healthcare resource utilization by copd patients: A comparison of three instruments. Qual Life Res 2002; 11: 739–751
   PubMed Web of Science ®Google Scholar
• Anie K A, Jones P W, Hilton S R, Anderson H R. A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol 1996; 49: 653–656
   PubMed Web of Science ®Google Scholar